Wall Street Analysts See a 33% Upside in Viatris (VTRS): Can the Stock Really Move This High?Zacks Investment Research • 10/22/21
Viatris' First-Ever Interchangeable Insulin Biosimilar Preferred on Express Scripts' Largest FormularyPRNewsWire • 10/20/21
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Viatris Inc. and Encourages Investors who Formerly Held Shares of Mylan Inc. (MYL) to Contact the FirmBusiness Wire • 09/29/21